News & Breakthroughs at Siteman
Stay informed with the latest cancer news and breakthroughs from Siteman Cancer Center. Our news feed provides timely updates on research breakthroughs, clinical trials, and community events.
Research News & Stories
Research
Timing may be key to effective cancer treatments
When doctors biopsy and treat cancer may be just as important as how they treat it. New research from Erik Herzog, PhD, the Viktor Hamburger Distinguished Professor in biology at Washington University in St. Louis and a research member at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine, revealed that when a treatment is given […]
Clinical, In the Media, Research
Connecting cancer patients to tobacco treatment is aim of $7.5 million, WashU-led trial
Cancer patients who quit smoking live significantly longer than those who don’t The science is clear: Cancer patients who quit smoking fare much better than those who don’t. Quitters respond better to treatment and are less likely to see their disease come back or develop a new cancer, and they have a lower risk of […]
In the Media, Research, Staff/Faculty Update
WashU researchers at Siteman honored with NIH Director’s awards
Three investigators recognized by high-risk, high-reward research program Three WashU researchers at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine have received prestigious and highly competitive awards through the National Institutes of Health (NIH) Director’s High-Risk, High-Reward Research program. The awards support unconventional approaches to major challenges in biomedical and behavioral research. Andrew L. Young, […]
Research
Breast cancer startup founded by WashU Medicine researchers acquired by Lunit
Prognosia’s AI-based imaging tech could improve prevention, early detection of breast cancer An innovative biotech startup founded by researchers at Washington University School of Medicine in St. Louis has been acquired by Lunit, a leading company in developing AI-based technologies for cancer prevention and early detection. The WashU startup, Prognosia, was created to develop software […]
Clinical, In the Media, Research
New center to develop AI-based imaging tools to improve diagnosis, care
WashU Medicine Mallinckrodt Institute of Radiology leads effort on image-based precision medicine Mallinckrodt Institute of Radiology (MIR) at Washington University School of Medicine in St. Louis is establishing a new center dedicated to developing AI-based imaging tools to improve the diagnosis and precision treatment of cancers, cardiovascular disease, neurological diseases and numerous other conditions. The […]
Research
Study sheds light on how pediatric brain tumors grow
Blocking a chemical messenger in the brain that helps tumor cells multiply could offer new route to treatment The most common type of brain tumor in children, pilocytic astrocytoma (PA), accounts for about 15% of all pediatric brain tumors. Although this type of tumor is usually not life-threatening, the unchecked growth of tumor cells can […]
Clinical, In the Media, Research
1,000th patient treated at Siteman with AI-enabled radiation therapy system
Combining artificial intelligence (AI) with advanced imaging, the technology supports more precise, personalized daily treatments by WashU Medicine physicians Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine has treated its 1,000th patient using state-of-the art radiation therapy technology that allows physicians to update a patient’s treatment plan on each day of treatment. Called adaptive […]
In the Media, Research
Working together, cells extend their senses
New research from Amit Pathak’s lab has implications for tracking cancer The story of the princess and the pea evokes an image of a highly sensitive royal young woman so refined, she can sense a pea under a stack of mattresses. When it comes to human biology, it also takes an abnormal individual to sense […]
In the Media, Research
AI-Based Breast Cancer Risk Technology Receives FDA Breakthrough Device Designation
Software developed at WashU Medicine on accelerated path to approval A new technology that harnesses AI to analyze mammograms and improve the accuracy of predicting a woman’s personalized five-year risk of developing breast cancer has received Breakthrough Device designation from the Food and Drug Administration (FDA). Developed by researchers at Washington University School of Medicine […]
In the Media, Research
Genetic study suggests ways to catch blood cancer earlier
New understanding of how mutations interact could pave way for early detection, prevention strategies As we age, our cells replicate, and the DNA in these cells can acquire mistakes — or mutations — every time the sequence is copied. Most newly acquired mutations are harmless, but some can tip the balance toward cancer development later […]